Availability

There are currently 7 dedicated products on the market:

• Gymiso® - 200µg tablets, France
• Prostokos® - 25µg vaginal tablets, Brazil
• Vagiprost® - 25µg vaginal tablets, Egypt
• U-Miso 200µg manufactured by U-Liang Ltd, Taiwan.
• Misoprost 600® - 600µg vaginal tablets, India (indicated for PPH prophylaxis)
• Zitotec® - 200µg or 100µg tablets, India

• Isprelor™ - 25µg vaginal tablets, UK
  Two phase III clinical trials of Isprelor^® have been completed. The results have been presented and published in the British Journal of Obstetrics and Gynaecology (BJOG-2008 Sep; 115(10):1279-88). Once clinical development is completed application for European Marketing Authorisation is planned.